GlassScriptPhysician profile
Emma R Scheick
NPI 1285294470
$3,187.28
in general payments reported to CMS, 2019-2025
18 companies · $61.13 in 2025
The $61.13 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,112 · 2022: $1,003 · 2023: $955 · 2024: $56.37 · 2025: $61.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $487.80 | 2021-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $446.69 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $443.08 | 2021-2023 | Farxiga |
| Esperion Therapeutics, INC. | $380.05 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $355.16 | 2021-2023 | Lifevest |
| Amgen INC. | $220.04 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $194.91 | 2022-2023 | Camzyos, Eliquis |
| Abbott Laboratories | $179.74 | 2021-2023 | Cardiomems |
| Cvrx, INC. | $97.37 | 2022-2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.31 | 2022-2023 | Jardiance |
| Stryker Corporation | $61.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $60.94 | 2023 | |
| Boston Scientific Corporation | $45.54 | 2023 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $43.52 | 2023 | |
| Heartflow, INC. | $23.01 | 2023 | Ffrct |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.28 | 2023 | Nuzyra |
| Lantheus Medical Imaging, INC. | $19.11 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $18.60 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Scheick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.